Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Complexing agents biological production

The frequent introduction of new pharmacotherapeu-tic agents into practice, the increasing complexity and technicality of new drugs and biologic products, and the evolution of pharmacotherapy practice necessitate that the pharmacotherapy specialist continually refine, improve, and expand the unique, advanced skills which he/ she possesses. [Pg.731]

Tetraaza ruthenium complexes, d5/tran5-[Ru(N)4LL ]" with N = NH3 or 12- to 16-memberedtetraazamacrocycle (Figure 2), are highly stable and can serve as a model to rmderstand thermodynamic control and photochemical reactions. In the presence of NO or N02 in acidic medium, a ds/[Pg.268]

In the early years of the chemical industry, use of biological agents centered on fermentation (qv) techniques for the production of food products, eg, vinegar (qv), cheeses (see Milk and milk products), beer (qv), and of simple organic compounds such as acetone (qv), ethanol (qv), and the butyl alcohols (qv). By the middle of the twentieth century, most simple organic chemicals were produced synthetically. Fermentation was used for food products and for more complex substances such as pharmaceuticals (qv) (see also Antibiotics). Moreover, supports were developed to immobilize enzymes for use in industrial processes such as the hydrolysis of starch (qv) (see Enzyme applications). [Pg.113]

Another factor that can possibly affect the redox potential in biological systems is the presence of secondary chelating agents that can participate in coupled equilibria (3). When other chelators are present, coupled equilibria involving iron-siderophore redox occur and a secondary ligand will cause the siderophore complex effective redox potential to shift. The decrease in stability of the iron-siderophore complex upon reduction results in a more facile release of the iron. Upon release, the iron(II) is available for complexation by the secondary ligand, which results in a corresponding shift in the redox equilibrium toward production of iron(II). In cases where iron(II) is stabilized by the secondary chelators, there is a shift in the redox potential to more positive values, as shown in Eqs. (42)—(45). [Pg.217]


See other pages where Complexing agents biological production is mentioned: [Pg.365]    [Pg.116]    [Pg.10]    [Pg.841]    [Pg.973]    [Pg.490]    [Pg.119]    [Pg.187]    [Pg.372]    [Pg.1365]    [Pg.973]    [Pg.423]    [Pg.13]    [Pg.402]    [Pg.146]    [Pg.123]    [Pg.32]    [Pg.4]    [Pg.296]    [Pg.7118]    [Pg.372]    [Pg.423]    [Pg.107]    [Pg.333]    [Pg.485]    [Pg.4624]    [Pg.398]    [Pg.75]    [Pg.643]    [Pg.599]    [Pg.7]    [Pg.118]    [Pg.55]    [Pg.2]    [Pg.264]    [Pg.283]    [Pg.208]    [Pg.223]    [Pg.134]    [Pg.253]    [Pg.56]    [Pg.468]    [Pg.473]    [Pg.201]    [Pg.46]   
See also in sourсe #XX -- [ Pg.494 ]




SEARCH



Biologic agents

Biological agents production

Biological complexity

Biological product

Biological production

Complexation agent

Complexation complexing agents

Complexes biological

Product complex

Product complexity

© 2024 chempedia.info